載入...
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
BACKGROUND: In patients stabilized during hospitalization for acute decompensated heart failure (ADHF), initiation of sacubitril/valsartan compared with enalapril decreased the risk of cardiovascular death or rehospitalization for heart failure (HF) without increasing the risk of adverse events. It...
Na minha lista:
| 發表在: | Circ Heart Fail |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7908815/ https://ncbi.nlm.nih.gov/pubmed/33530704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.007034 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|